Acquisition of Inverted GSTM Exons by an Intron of Primate GSTM5 Gene
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Systems and Chemical Biology Approaches to Study Cell Function and Response to Toxins
Dissertation submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences Presented by MSc. Yingying Jiang born in Shandong, China Oral-examination: Systems and chemical biology approaches to study cell function and response to toxins Referees: Prof. Dr. Rob Russell Prof. Dr. Stefan Wölfl CONTRIBUTIONS The chapter III of this thesis was submitted for publishing under the title “Drug mechanism predominates over toxicity mechanisms in drug induced gene expression” by Yingying Jiang, Tobias C. Fuchs, Kristina Erdeljan, Bojana Lazerevic, Philip Hewitt, Gordana Apic & Robert B. Russell. For chapter III, text phrases, selected tables, figures are based on this submitted manuscript that has been originally written by myself. i ABSTRACT Toxicity is one of the main causes of failure during drug discovery, and of withdrawal once drugs reached the market. Prediction of potential toxicities in the early stage of drug development has thus become of great interest to reduce such costly failures. Since toxicity results from chemical perturbation of biological systems, we combined biological and chemical strategies to help understand and ultimately predict drug toxicities. First, we proposed a systematic strategy to predict and understand the mechanistic interpretation of drug toxicities based on chemical fragments. Fragments frequently found in chemicals with certain toxicities were defined as structural alerts for use in prediction. Some of the predictions were supported with mechanistic interpretation by integrating fragment- chemical, chemical-protein, protein-protein interactions and gene expression data. Next, we systematically deciphered the mechanisms of drug actions and toxicities by analyzing the associations of drugs’ chemical features, biological features and their gene expression profiles from the TG-GATEs database. -
Herpes Simplex Virus Blocks Host Transcription Termination Via the Bimodal Activities of ICP27
ARTICLE https://doi.org/10.1038/s41467-019-14109-x OPEN Herpes simplex virus blocks host transcription termination via the bimodal activities of ICP27 Xiuye Wang 1, Thomas Hennig2, Adam W. Whisnant 2, Florian Erhard 2, Bhupesh K. Prusty 2, Caroline C. Friedel 3, Elmira Forouzmand4,5, William Hu1, Luke Erber 6, Yue Chen6, Rozanne M. Sandri-Goldin 1*, Lars Dölken 2,7* & Yongsheng Shi1* Infection by viruses, including herpes simplex virus-1 (HSV-1), and cellular stresses cause 1234567890():,; widespread disruption of transcription termination (DoTT) of RNA polymerase II (RNAPII) in host genes. However, the underlying mechanisms remain unclear. Here, we demonstrate that the HSV-1 immediate early protein ICP27 induces DoTT by directly binding to the essential mRNA 3’ processing factor CPSF. It thereby induces the assembly of a dead-end 3’ processing complex, blocking mRNA 3’ cleavage. Remarkably, ICP27 also acts as a sequence- dependent activator of mRNA 3’ processing for viral and a subset of host transcripts. Our results unravel a bimodal activity of ICP27 that plays a key role in HSV-1-induced host shutoff and identify CPSF as an important factor that mediates regulation of transcription termination. These findings have broad implications for understanding the regulation of transcription termination by other viruses, cellular stress and cancer. 1 Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA. 2 Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany. 3 Institute of Informatics, Ludwig-Maximilians-Universität München, München, Germany. 4 Institute for Genomics and Bioinformatics, University of California, Irvine, Irvine, CA 92697, USA. -
GSTM4 Is a Microsatellite-Containing EWS&Sol;FLI Target Involved in Ewing&Apos;S Sarcoma Oncogenesis and Therapeutic
Oncogene (2009) 28, 4126–4132 & 2009 Macmillan Publishers Limited All rights reserved 0950-9232/09 $32.00 www.nature.com/onc SHORT COMMUNICATION GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing’s sarcoma oncogenesis and therapeutic resistance W Luo1,2, K Gangwal1,2, S Sankar1,2, KM Boucher1, D Thomas3 and SL Lessnick1,2,4 1Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA; 2The Center for Children’s Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; 3Department of Pathology, University of Michigan, Ann Arbor, MI, USA and 4Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA Ewing’s sarcoma is a malignant bone-associated tumor of Most cases of Ewing’s sarcoma harbor recurrent children and young adults. Most cases of Ewing’s sarcoma chromosomal translocations, the most common express the EWS/FLI fusion protein. EWS/FLI functions of which encodes the EWS/FLI fusion oncoprotein as an aberrant ETS-type transcription factor and serves (Delattre et al., 1992). EWS/FLI requires both its strong as the master regulator of Ewing’s sarcoma-transformed transcriptional activation domain (derived from EWS) phenotype. We recently showed that EWS/FLI regulates and its ETS-type DNA-binding domain (derived from one of its key targets, NR0B1, through a GGAA- FLI) for oncogenic function (May et al., 1993a, b). A microsatellite in its promoter. Whether other critical variety of studies have identified a large number of EWS/FLI targets are also regulated by GGAA-micro- EWS/FLI-regulated genes (Prieur et al., 2004; Smith satellites was unknown. -
Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A. -
GSTM4 (1-218, His-Tag) Human Protein – AR09587PU-L | Origene
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AR09587PU-L GSTM4 (1-218, His-tag) Human Protein Product data: Product Type: Recombinant Proteins Description: GSTM4 (1-218, His-tag) human recombinant protein, 0.5 mg Species: Human Expression Host: E. coli Tag: His-tag Predicted MW: 27.7 kDa Concentration: lot specific Purity: >95% by SDS - PAGE Buffer: Presentation State: Purified State: Liquid purified protein Buffer System: 20 mM Tris-HCl buffer (pH 8.0) containing 1 mM DTT, 10% glycerol, 50 mM NaCl Preparation: Liquid purified protein Protein Description: Recombinant human GSTM4 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. Storage: Store undiluted at 2-8°C for up to two weeks or (in aliquots) at -20°C or -70°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. RefSeq: NP_000841 Locus ID: 2948 UniProt ID: Q03013, A0A140VKE3 Cytogenetics: 1p13.3 Synonyms: GSTM4-4; GTM4 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 GSTM4 (1-218, His-tag) Human Protein – AR09587PU-L Summary: Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. -
WDR33 (NM 001006623) Human Tagged ORF Clone Product Data
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC216403L3 WDR33 (NM_001006623) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: WDR33 (NM_001006623) Human Tagged ORF Clone Tag: Myc-DDK Symbol: WDR33 Synonyms: NET14; WDC146 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC216403). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_001006623 ORF Size: 771 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 WDR33 (NM_001006623) Human Tagged ORF Clone – RC216403L3 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_001006623.1 RefSeq Size: 3574 bp RefSeq ORF: 774 bp Locus ID: 55339 UniProt ID: Q9C0J8 Protein Families: Stem cell - Pluripotency MW: 30.1 kDa Gene Summary: This gene encodes a member of the WD repeat protein family. -
Molecular Basis for the Recognition of the Human AAUAAA Polyadenylation Signal
Molecular basis for the recognition of the human PNAS PLUS AAUAAA polyadenylation signal Yadong Suna,1, Yixiao Zhangb,1, Keith Hamiltona, James L. Manleya,2, Yongsheng Shic, Thomas Walzb,2, and Liang Tonga,2 aDepartment of Biological Sciences, Columbia University, New York, NY 10027; bLaboratory of Molecular Electron Microscopy, Rockefeller University, New York, NY 10065; and cDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, CA 92697 Contributed by James L. Manley, November 14, 2017 (sent for review October 26, 2017; reviewed by Nick J. Proudfoot and Joan A. Steitz) Nearly all eukaryotic messenger RNA precursors must undergo polymerase] (17). CPSF-73 and CPSF-100 together with sym- cleavage and polyadenylation at their 3′-end for maturation. A plekin form the other component, also known as the core crucial step in this process is the recognition of the AAUAAA poly- cleavage complex (24) or mCF (mammalian cleavage factor) (5), adenylation signal (PAS), and the molecular mechanism of this which catalyzes the cleavage reaction. Symplekin is a scaffold recognition has been a long-standing problem. Here, we report protein and also mediates interactions with CstF and other fac- the cryo-electron microscopy structure of a quaternary complex tors in the 3′-end processing machinery (25–28). of human CPSF-160, WDR33, CPSF-30, and an AAUAAA RNA at CPSF-160 (160 kDa) contains three β-propeller domains 3.4-Å resolution. Strikingly, the AAUAAA PAS assumes an unusual (BPA, BPB, and BPC) and a C-terminal domain (CTD) (Fig. conformation that allows this short motif to be bound directly by 1A), and shares weak sequence homology to the DNA damage- both CPSF-30 and WDR33. -
WDR33 (Human) Recombinant Protein (P01)
WDR33 (Human) Recombinant Gene Summary: This gene encodes a member of the Protein (P01) WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids Catalog Number: H00055339-P01 typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or Regulation Status: For research use only (RUO) multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell Product Description: Human WDR33 full-length ORF ( cycle progression, signal transduction, apoptosis, and NP_001006623.1, 1 a.a. - 326 a.a.) recombinant protein gene regulation. This gene is highly expressed in testis with GST-tag at N-terminal. and the protein is localized to the nucleus. This gene may play important roles in the mechanisms of Sequence: cytodifferentiation and/or DNA recombination. Multiple MATEIGSPPRFFHMPRFQHQAPRQLFYKRPDFAQQQ alternatively spliced transcript variants encoding distinct AMQQLTFDGKRMRKAVNRKTIDYNPSVIKYLENRIWQ isoforms have been found for this gene. [provided by RDQRDMRAIQPDAGYYNDLVPPIGMLNNPMNAVTTKF RefSeq] VRTSTNKVKCPVFVVRWTPEGRRLVTGASSGEFTLW NGLTFNFETILQAHDSPVRAMTWSHNDMWMLTADHG GYVKYWQSNMNNVKMFQAHKEAIREARFIHNIPFSVV PIVMVKLFSKCILGAEMHGLCQFLGNFLHPINTIFFFVFT HSPFCWHLSEVVLSRYQPLQYVRDVLSAAFCTGFLFS FMINNVYTLFLFIIYCVRQEYFIPNKEFSL Host: Wheat Germ (in vitro) Theoretical MW (kDa): 64.7 Applications: AP, Array, ELISA, WB-Re (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Preparation Method: in vitro wheat germ expression system Purification: Glutathione Sepharose 4 Fast Flow Storage Buffer: 50 mM Tris-HCI, 10 mM reduced Glutathione, pH=8.0 in the elution buffer. Storage Instruction: Store at -80°C. Aliquot to avoid repeated freezing and thawing. Entrez GeneID: 55339 Gene Symbol: WDR33 Gene Alias: FLJ11294, WDC146 Page 1/1 Powered by TCPDF (www.tcpdf.org). -
Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo -
Snps in Genes Coding for ROS Metabolism and Signalling in Association with Docetaxel Clearance
The Pharmacogenomics Journal (2010) 10, 513–523 & 2010 Macmillan Publishers Limited. All rights reserved 1470-269X/10 www.nature.com/tpj ORIGINAL ARTICLE SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance H Edvardsen1,2, PF Brunsvig3, The dose of docetaxel is currently calculated based on body surface area 1,4 5 and does not reflect the pharmacokinetic, metabolic potential or genetic H Solvang , A Tsalenko , background of the patients. The influence of genetic variation on the 6 7 A Andersen , A-C Syvanen , clearance of docetaxel was analysed in a two-stage analysis. In step one, 583 Z Yakhini5, A-L Børresen-Dale1,2, single-nucleotide polymorphisms (SNPs) in 203 genes were genotyped on H Olsen6, S Aamdal3 and samples from 24 patients with locally advanced non-small cell lung cancer. 1,2 We found that many of the genes harbour several SNPs associated with VN Kristensen clearance of docetaxel. Most notably these were four SNPs in EGF, three SNPs 1Department of Genetics, Institute of Cancer in PRDX4 and XPC, and two SNPs in GSTA4, TGFBR2, TNFAIP2, BCL2, DPYD Research, Oslo University Hospital Radiumhospitalet, and EGFR. The multiple SNPs per gene suggested the existence of common Oslo, Norway; 2Institute of Clinical Medicine, haplotypes associated with clearance. These were confirmed with detailed 3 University of Oslo, Oslo, Norway; Cancer Clinic, haplotype analysis. On the basis of analysis of variance (ANOVA), quantitative Oslo University Hospital Radiumhospitalet, Oslo, Norway; 4Institute of -
Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ...................................................... -
Protein Sequence Comparison and Protein Evolution Tutorial
Protein sequence comparison and Protein evolution Tutorial - ISMB2000 William R. Pearson∗ Department of Biochemistry and Molecular Genetics, Jordan Hall, Box 800733 University of Virginia, Charlottesville, VA 22908, USA October, 2001 Contents 1 Introduction 2 1.1 Evolutionary time scales . 4 1.2 Similarity, Ancestry and Structure . 6 1.3 Modes of Evolution . 8 1.3.1 Conventional divergence from a common ancestor . 8 1.3.2 Sequence similarity and homology, the H+ ATPase . 10 1.3.3 Protein families diverge at different rates . 16 1.3.4 Mosaic proteins . 18 1.4 Introns Early/Late . 18 1.5 DNA vs Protein comparison . 19 2 Alignment methods 22 2.1 Algorithms . 22 2.2 Dynamic Programming Algorithms . 25 2.3 Heuristic Algorithms . 27 ∗FAX: (804) 924-5069; email: [email protected] 1 2.3.1 BLAST . 29 2.3.2 FASTA . 29 3 The statistics of sequence similarity scores 30 3.1 Sequence alignments without gaps . 31 3.2 Scoring matrices . 31 3.3 Empirical statistics for alignments with gaps . 35 3.4 Statistical significance by random shuffling . 36 4 Identifying distantly related protein sequences 36 4.1 Serine proteases . 37 4.2 Glutathione S-transferases . 42 4.3 G-protein-coupled receptors . 43 5 Repeated structures in proteins 46 6 Summary 48 References 50 7 Suggested Reading 52 7.1 General Protein evolution . 52 7.1.1 Introns Early/Late . 52 7.2 Alignment methods . 52 7.2.1 Algorithms . 52 7.2.2 Scoring methods . 53 7.3 Evaluating matches - statistics of similarity scores . 53 1 Introduction The concurrent development of molecular cloning techniques, DNA sequencing methods, rapid sequence comparison algorithms, and computer workstations has revolutionized the role of biological sequence comparison in molecular biology.